Comparative study of the speed of acid-suppressing effects of oral administration of cimetidine and famotidine

被引:12
作者
Adachi, K [1 ]
Komazawa, Y [1 ]
Mihara, T [1 ]
Azumi, T [1 ]
Fujisawa, T [1 ]
Katsube, T [1 ]
Furuta, K [1 ]
Kinoshita, Y [1 ]
机构
[1] Shimane Univ, Sch Med, Dept Gastroenterol & Hepatol, Izumo, Shimane 6938501, Japan
关键词
antisecretory efficacy; cimetidine; famotidine; pH monitoring;
D O I
10.1111/j.1440-1746.2005.03917.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and Aims: H2 histamine receptor antagonists (H2RAs) are widely used in patients with acid-related diseases, and the onset of antisecretory activity of H2RAs is reported to be faster than that of proton pump inhibitors (PPIs). The aim of this study was to compare the rapidity of onset of antisecretory activity of cimetidine and famotidine when orally administered. Methods: Fifteen healthy male Japanese volunteers (five H. pylori-positive and 10 H. pylori-negative) participated in a randomized cross-over study. All subjects were examined three times by ambulatory 6-h pH monitoring (from 17:30 to 23:30) with no medication or oral administration of 400 mg of cimetidine or 20 mg of famotidine. Drugs were administered at 19:30 after eating a standard meal, and plasma concentrations were also examined for 4 h periods. Results: The plasma concentration of cimetidine increased rapidly after oral administration, while that of famotidine increased gradually. Intragastric pH was increased and percentage time with pH < 4.0 decreased significantly 2 h after administration of either cimetidine or famotidine. There was no statistically significant difference in acid-suppressing effect between cimetidine and famotidine during the short-term post-administration period. Conclusion: Rapidity of antisecretory activity did not differ between oral cimetidine and famotidine administered orally. (C) 2005 Blackwell Publishing Asia Pty Ltd.
引用
收藏
页码:1012 / 1015
页数:4
相关论文
共 19 条
[1]   The comparative effects of single intravenous doses of omeprazole and famotidine on intragastric pH [J].
Abe, Y ;
Inamori, M ;
Togawa, J ;
Kikuchi, T ;
Muramatsu, K ;
Chiguchi, G ;
Kawamura, H ;
Kobayashi, N ;
Kirikoshi, H ;
Sakaguchi, T ;
Takamura, T ;
Nakajima, A ;
Ueno, N ;
Sekihara, H .
JOURNAL OF GASTROENTEROLOGY, 2004, 39 (01) :21-25
[2]   Influence of lansoprazole, famotidine, roxatidine and rebamipide administration on the urea breath test for the diagnosis of Helicobacter pylori infection [J].
Adachi, K ;
Fujishiro, H ;
Mihara, T ;
Komazawa, Y ;
Kinoshita, Y .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2003, 18 (02) :168-171
[3]   Comparative evaluation of urine-based and other minimally invasive methods for the diagnosis of Helicobacter pylori infection [J].
Adachi, K ;
Kawamura, A ;
Ono, M ;
Masuzaki, K ;
Takashima, T ;
Yuki, M ;
Fujishiro, H ;
Ishihara, S ;
Kinoshita, Y .
JOURNAL OF GASTROENTEROLOGY, 2002, 37 (09) :703-708
[4]   APPROPRIATE ACID SUPPRESSION FOR THE MANAGEMENT OF GASTROESOPHAGEAL REFLUX DISEASE [J].
BELL, NJV ;
BURGET, D ;
HOWDEN, CW ;
WILKINSON, J ;
HUNT, RH .
DIGESTION, 1992, 51 :59-67
[5]   The comparative effects of single intravenous doses of cimetidine, ranitidine, famotidine, and omeprazole on intragastric pH [J].
Chassany, O ;
Bergmann, JF ;
Simoneau, G ;
ElouaerBlanc, L ;
Segrestaa, JM ;
Caulin, C .
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1996, 57 (03) :159-167
[6]  
DeVault KR, 1999, AM J GASTROENTEROL, V94, P1434
[7]   Gastric Helicobacter pylori infection accelerates healing of reflux esophagitis during treatment with the proton pump inhibitor pantoprazole [J].
Holtmann, G ;
Cain, C ;
Malfertheiner, P .
GASTROENTEROLOGY, 1999, 117 (01) :11-16
[8]  
HOWDEN CW, 1992, HEPATO-GASTROENTEROL, V39, P45
[9]   OPTIMIZING ACID SUPPRESSION FOR TREATMENT OF ACID-RELATED DISEASES [J].
HUNT, RH ;
CEDERBERG, C ;
DENT, J ;
HALTER, F ;
HOWDEN, C ;
MARKS, INS ;
RUNE, S ;
WALT, RP .
DIGESTIVE DISEASES AND SCIENCES, 1995, 40 (02) :S24-S49
[10]   COMPARISON OF ACID INHIBITION BY EITHER ORAL HIGH-DOSE RANITIDINE OR OMEPRAZOLE [J].
HURLIMANN, S ;
ABBUHL, B ;
INAUEN, W ;
HALTER, F .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1994, 8 (02) :193-201